NCT01910129View on ClinicalTrials.gov

Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy

NATerminatedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

October 31, 2014

Conditions

Seizure

Interventions

DEVICE

gammaCore

vagal verve stimulation 3 times a day 8 hours apart

Trial Locations (2)

2067

Strategic Health Evaluators, Sydney

2217

Southern Neurology, Kogarah

Sponsors

Lead Sponsor

ElectroCore INC

All Listed Sponsors

lead

ElectroCore INC

INDUSTRY

NCT01910129 - Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy | Biotech Hunter | Biotech Hunter